TwinBeech Capital’s Integra LifeSciences IART Stock Holding History
Bought
Maintained
Sold
Other funds holding IART
RCMNY
PCMI
TwinBeech Capital's IART Position: Q3 2025 in Review
TwinBeech Capital sold out of Integra LifeSciences (IART) in Q3 2025, closing a stake of 185,992 shares — an estimated $2.28M sold.
TwinBeech Capital first reported a position in IART in Q1 2020 and held it in 12 quarters. The position peaked at $6.14M in Q3 2024. 207 funds tracked by Wall St. Rank hold IART as of Q3 2025.
- TwinBeech Capital reported no remaining Integra LifeSciences position as of Q3 2025 after selling out during the quarter.
- TwinBeech Capital sold 185,992 Integra LifeSciences shares in Q3 2025, an estimated $2.28M.
- TwinBeech Capital first reported a position in Integra LifeSciences in Q1 2020 and held it in 12 quarters.
- TwinBeech Capital's Integra LifeSciences position peaked at $6.14M in Q3 2024.
- 207 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2025.
Based on TwinBeech Capital's 13F filing for Q3 2025, filed 14 Nov 2025.